American Century Companies’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.45M Sell
318,193
-31,227
-9% -$437K ﹤0.01% 1719
2025
Q1
$4.75M Sell
349,420
-131,109
-27% -$1.78M ﹤0.01% 1626
2024
Q4
$9.79M Buy
480,529
+29,155
+6% +$594K 0.01% 1336
2024
Q3
$13.1M Sell
451,374
-71,220
-14% -$2.07M 0.01% 1202
2024
Q2
$12.1M Buy
522,594
+63,058
+14% +$1.46M 0.01% 1164
2024
Q1
$9.43M Sell
459,536
-13,958
-3% -$286K 0.01% 1229
2023
Q4
$10.2M Sell
473,494
-842
-0.2% -$18.1K 0.01% 1139
2023
Q3
$9.79M Buy
474,336
+427
+0.1% +$8.81K 0.01% 1073
2023
Q2
$14M Buy
473,909
+126
+0% +$3.72K 0.01% 917
2023
Q1
$10.9M Buy
473,783
+1,495
+0.3% +$34.4K 0.01% 983
2022
Q4
$13.1M Sell
472,288
-86
-0% -$2.39K 0.01% 869
2022
Q3
$14.5M Buy
472,374
+3,093
+0.7% +$94.9K 0.01% 760
2022
Q2
$13.8M Sell
469,281
-67,190
-13% -$1.98M 0.01% 795
2022
Q1
$17.3M Buy
536,471
+189
+0% +$6.08K 0.01% 727
2021
Q4
$23.9M Buy
536,282
+187,295
+54% +$8.35M 0.02% 654
2021
Q3
$17.6M Buy
348,987
+56,140
+19% +$2.83M 0.01% 705
2021
Q2
$23M Buy
292,847
+1,605
+0.6% +$126K 0.02% 641
2021
Q1
$16.6M Sell
291,242
-33,646
-10% -$1.92M 0.01% 678
2020
Q4
$27.2M Sell
324,888
-91,588
-22% -$7.67M 0.02% 539
2020
Q3
$14.9M Buy
416,476
+130
+0% +$4.66K 0.01% 614
2020
Q2
$10.1M Buy
416,346
+225
+0.1% +$5.44K 0.01% 670
2020
Q1
$7.29M Sell
416,121
-10,926
-3% -$191K 0.01% 664
2019
Q4
$7.44M Sell
427,047
-59,687
-12% -$1.04M 0.01% 745
2019
Q3
$7.46M Hold
486,734
0.01% 682
2019
Q2
$10.1M Buy
486,734
+233,440
+92% +$4.85M 0.01% 630
2019
Q1
$5.88M Buy
+253,294
New +$5.88M 0.01% 766